What's Going On With TG Therapeutics Stock Tuesday?

1 day ago · TG Therapeutics expects fourth-quarter BRIUMVI net product revenue in the U.S. to be $103.6 million. TG Therapeutics says it expects to report a 2024 year-end cash position of approximately $310 ...

$103
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

benzinga.com

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

15 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

7%
OFF

TG Therapeutics Shares Climb 7% As Sales Grow For ... - MarketWatch

2 weeks from now

Shares were up 7.7% Tuesday to $29.79. The stock is about 18% below its 52-week high of $36.84. ... TG Therapeutics also said it expects total global revenue around $540 million in …

marketwatch.com

$20.00
OFF

TG Therapeutics (NASDAQ:TGTX) Rating Increased To Hold At

2 weeks from now

Jan 8, 2025 · The Goldman Sachs Group increased their price target on TG Therapeutics from $20.00 to $22.00 and gave the stock a "neutral" rating in a report on Tuesday, November 5th. …

marketbeat.com

18%
OFF

What's Going On With TG Therapeutics Stock? - Benzinga

2 weeks from now

Jan 9, 2024 · TG Therapeutics, Inc. TGTX shares are trading lower Tuesday, though the stock remains up 18% over the past five days. Here's a look at what's going on.. What To Know: TG …

benzinga.com

38%
OFF

Why Shares Of TG Therapeutics Soared On Tuesday

2 weeks from now

Apr 11, 2023 · Shares of TG Therapeutics (TGTX 0.38%) were up by 18% as of mid-afternoon Tuesday after reports that the biotech's multiple sclerosis therapy Briumvi would have better …

fool.com

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Stock Price Down 2.4% – What’s …

2 weeks from now

Jan 2, 2025 · TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report)’s stock price dropped 2.4% during trading on Tuesday . The stock traded as low as $30.61 and last traded at $30.68. …

etfdailynews.com

40%
OFF

What's Going On With TG Therapeutics Stock Today?

2 weeks from now

Aug 1, 2023 · TG Therapeutics Inc (NASDAQ:TGTX) shares are down over 40%. The company reported Q2 FY23 Briumvi net sales of $16 million in the U.S., with total net revenue of …

businessinsider.com

$55
OFF

TG Therapeutics Price Target Raised To $55 From $49 At H.C

2 weeks from now

Nov 4, 2024 · H.C. Wainwright raised the firm’s price target on TG Therapeutics (TGTX) to $55 from $49 and keeps a Buy rating on the shares. TG Therapeutics reported Q3 results, …

nasdaq.com

$10
OFF

TG Therapeutics Price Target Raised To $10 From $9 At BofA

2 weeks from now

Jan 7, 2025 · BofA raised the firm’s price target on TG Therapeutics to $10 from $9 and keeps an Underperform rating on the shares.While political and rate uncertainty continues to be an …

businessinsider.com

10%
OFF

Why TGTX Stock Is Rallying Today - MSN

2 weeks from now

TG Therapeutics' 2025 Guidance and Comments. ... The Price Action of TG Stock. In the last month the shares have fallen 10%, despite today's rally. However, they have advanced 23% in …

msn.com

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today

2 weeks from now

Nov 30, 2021 · Shares of biopharma outfit TG Therapeutics (TGTX-6.82%) are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the company announced the U.S. Food and Drug …

fool.com

93%
OFF

Tg Therapeutics Stock Price Forecast. Should You Buy TGTX?

2 weeks from now

Jan 7, 2025 · Sell candidate since Dec 27, 2024 Loss -13.93%. No changes to the price of TG Therapeutics stock on the last trading day (Tuesday, 7th Jan 2025). During the last trading day …

stockinvest.us

FAQs about What's Going On With TG Therapeutics Stock Tuesday? Coupon?

Why did TG Therapeutics stock rise?

By Owen Tucker-Smith Shares of TG Therapeutics rose after the company raised its guidance on better-than-expected sales of its multiple sclerosis drug. Shares were up 7.7% Tuesday to $29.79. The stock is about 18% below its 52-week high of $36.84. ...

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

What happened to TG Therapeutics (tgtx) stock?

TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report)’s stock price dropped 2.4% during trading on Tuesday . The stock traded as low as $30.61 and last traded at $30.68. Approximately 366,002 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 3,526,031 shares. The stock had previously closed at $31.45. ...

Where can I buy shares of TG Therapeutics?

Shares of TGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TG Therapeutics own? ...

Is TG Therapeutics a good stock to buy?

TG Therapeutics has seen financial growth and decline over the past few years. The company has reported significant losses primarily due to removing Ukoniq from its product line and increased investment in clinical development and research activities. TG Therapeutics has seen significant volatility in its stock price over the past few years. ...

Why did TG Therapeutics stock crash Monday?

TG Therapeutics stock crashed Monday after missing profit expectations, though sales of its multiple sclerosis treatment beat forecasts. TG Therapeutics (TGTX) delivered earnings and revenue surprises of -50% and 4.46%, respectively, for the quarter ended September 2024. ...